Guanfacine Tablet, Extended Release
Product Images NDC 60760-863

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Guanfacine (NDC 60760-863). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

863-.30 (Guanfacine 60760 863 30)

863-.30 (Guanfacine 60760 863 30)
This text appears to be a pharmaceutical label for Guanfacine extended-release tablets. The tablets are in 1mg dosage form and come in a quantity of 30 tablets per container. The manufacturer is Alembic Pharmaceuticals Limited in Gujarat, India. The label emphasizes the importance of using the medication as directed and contains storage instructions to store at a controlled room temperature. It also includes batch numbers, expiration dates, and the National Drug Code (NDC) for identification purposes.*
FDA Label Image

Figure2 (Guanfacine 2figure)

FDA Label Image

Figure 3 (Guanfacine 3 Figure)

Figure 3 (Guanfacine 3 Figure)
This text provides information on the interacting drug PK fold change and 90% confidence interval for oral Methylphenidate and Lisdexamfetamine Dimesylate, specifically regarding Cmax and AUC values. The data seems to compare the changes relative to a reference, possibly related to drug interactions.*
FDA Label Image

Figure1 (Guanfacine Figure 1)

FDA Label Image

Figure 4 (Guanfacine Figure4)

FDA Label Image

Structure (Guanfacine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.